Visuospatial and Attentional Abilities Predict Driving Simulator Performance Among Older HIV-infected Adults

Am J Alzheimers Dis Other Demen. 2013 Mar;28(2):185-94. doi: 10.1177/1533317512473192. Epub 2013 Jan 11.

Abstract

Objectives: To examine the effects of aging and neuropsychological (NP) impairment on driving simulator performance within a human immunodeficiency virus (HIV)-infected cohort.

Methods: Participants included 79 HIV-infected adults (n = 58 > age 50, n = 21 ≤ 40) who completed a NP battery and a personnel computer-based driving simulator task. Outcome variables included total completion time (time) and number of city blocks to complete the task (blocks).

Results: Compared to the younger group, the older group was less efficient in their route finding (blocks over optimum: 25.9 [20.1] vs 14.4 [16.9]; P = .02) and took longer to complete the task (time: 1297.6 [577.6] vs 804.4 [458.5] seconds; P = .001). Regression models within the older adult group indicated that visuospatial abilities (blocks: b = -0.40, P <.001; time: b = -0.40, P = .001) and attention (blocks: b = -0.49, P = .001; time: b = -0.42, P = .006) independently predicted simulator performance. The NP-impaired group performed more poorly on both time and blocks, compared to the NP normal group.

Conclusions: Older HIV-infected adults may be at risk of driving-related functional compromise secondary to HIV-associated neurocognitive decline.

Trial registration: ClinicalTrials.gov NCT00675766.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Accidents, Traffic
  • Adult
  • Aged
  • Aging / physiology
  • Aging / psychology*
  • Attention / physiology*
  • Automobile Driving / psychology*
  • Cohort Studies
  • Computer Simulation
  • Female
  • HIV Infections / psychology*
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Psychomotor Performance*
  • Regression Analysis
  • Space Perception / physiology*
  • Visual Perception / physiology
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT00675766